Oak Associates’s Bio-Techne TECH Stock Holding History

Oak Associates’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-54,000	Closed	-$1.52M	–	175
2016 Q2	$1.52M	Hold	54,000	–	–	0.18%	102
2016 Q1	$1.28M	Hold	54,000	–	–	0.16%	99
2015 Q4	$1.22M	Hold	54,000	–	–	0.14%	105
2015 Q3	$1.25M	Hold	54,000	–	–	0.17%	99
2015 Q2	$1.33M	Hold	54,000	–	–	0.16%	104
2015 Q1	$1.35M	Hold	54,000	–	–	0.16%	105
2014 Q4	$1.25M	Hold	54,000	–	–	0.15%	106
2014 Q3	$1.26M	Hold	54,000	–	–	0.16%	108
2014 Q2	$1.25M	Hold	54,000	–	–	0.15%	108
2014 Q1	$1.15M	Hold	54,000	–	–	0.14%	106
2013 Q4	$1.28M	Buy	+54,000	New	+$1.17M	0.14%	101
2013 Q2	$933K	Buy	+54,000	New	+$896K	0.11%	110

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Oak Associates's TECH Position: Q3 2016 in Review

Oak Associates sold out of Bio-Techne (TECH) in Q3 2016, closing a stake of 54,000 shares — an estimated $1.52M sold.

Oak Associates first reported a position in TECH in Q2 2013 and held it in 12 quarters. The position peaked at $1.52M in Q2 2016. 294 funds tracked by Wall St. Rank hold TECH as of Q3 2016.

Oak Associates reported no remaining Bio-Techne position as of Q3 2016 after selling out during the quarter.
Oak Associates sold 54,000 Bio-Techne shares in Q3 2016, an estimated $1.52M.
Oak Associates first reported a position in Bio-Techne in Q2 2013 and held it in 12 quarters.
Oak Associates's Bio-Techne position peaked at $1.52M in Q2 2016.
294 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2016.

Based on Oak Associates's 13F filing for Q3 2016, filed 9 Nov 2016.